Accesswire
14 Aug 2026, 22:50 UTC · 2h ago
Revive Therapeutics Reports Grant of Options
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Accesswire
14 Aug 2026, 22:50 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Revive Therapeutics granted 15,500,000 incentive stock options to directors, officers, and consultants. — Large grants of stock options create potential future share dilution for existing shareholders.
-0.30The granted stock options have an exercise price of $0.05 per share. — The set exercise price provides a baseline valuation benchmark for the company's internal incentive structure.
+0.10Which stocks this story touches
The company is implementing an incentive plan to drive performance and reward key personnel.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
10h ago
